Stock listing
NASDAQ:GLUE Monte Rosa Therapeutics, Inc. Stock
Home listing (NASDAQ) of Monte Rosa Therapeutics, Inc.
Follow Monte Rosa Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:GLUE
$10.63 USD -0.13 (-1.2%)
Close on Nov 2, 2026
- Day range
- $10.43 – $11.02 USDNov 2, 2026
- Volume
- 1.77M sharesNov 2, 2026
- Market cap
- $906.9M USDAt the close on Nov 2, 2026 · price × 85.31M shares outstanding
- 52-week range
- $9.68 – $25.77 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $16.56M USDMedian day 1.15M shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:GLUE · Home | $10.63 USD | -0.13 (-1.2%) | 1,767,020 | $10.79 | $11.02 | $10.43 | $10.76 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:GLUE · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $10.63 | -0.13 | -1.2% | $10.79 | $11.02 | $10.43 | 1,767,020 | |
| $10.76 | -0.11 | -1.0% | $10.85 | $11.13 | $10.45 | 1,349,050 | |
| $10.87 | +0.02 | +0.2% | $11.00 | $11.20 | $10.73 | 1,307,285 | |
| $10.85 | +0.19 | +1.8% | $10.51 | $10.88 | $10.40 | 1,625,040 | |
| $10.66 | +0.18 | +1.7% | $10.47 | $10.71 | $10.34 | 1,457,934 | |
| $10.48 | -0.36 | -3.3% | $10.94 | $10.94 | $10.33 | 1,227,110 | |
| $10.84 | -0.27 | -2.4% | $11.03 | $11.03 | $10.61 | 817,827 | |
| $11.11 | -0.11 | -1.0% | $11.14 | $11.39 | $11.00 | 1,284,514 | |
| $11.22 | -0.14 | -1.2% | $11.38 | $11.74 | $11.09 | 1,080,022 | |
| $11.36 | +0.70 | +6.6% | $10.72 | $11.42 | $10.56 | 1,865,618 | |
| $10.66 | +0.92 | +9.4% | $9.84 | $10.71 | $9.76 | 1,925,835 | |
| $9.74 | -0.38 | -3.8% | $10.18 | $10.23 | $9.705 | 885,433 | |
| $10.12 | +0.28 | +2.8% | $9.95 | $10.24 | $9.88 | 1,543,915 | |
| $9.84 | -0.05 | -0.5% | $9.76 | $10.11 | $9.71 | 1,092,893 | |
| $9.89 | -0.63 | -6.0% | $10.45 | $10.54 | $9.853 | 2,714,008 | |
| $10.52 | +0.22 | +2.1% | $10.29 | $10.63 | $10.14 | 2,094,587 | |
| $10.30 | -0.02 | -0.2% | $10.36 | $10.52 | $10.21 | 1,201,739 | |
| $10.32 | +0.15 | +1.5% | $10.04 | $10.38 | $9.82 | 1,886,607 | |
| $10.17 | +0.30 | +3.0% | $9.84 | $10.75 | $9.68 | 2,081,663 | |
| $9.87 | -0.40 | -3.9% | $10.38 | $10.38 | $9.78 | 1,052,878 | |
| $10.27 | -0.23 | -2.2% | $10.56 | $10.59 | $10.04 | 1,749,262 | |
| $10.50 | -0.76 | -6.7% | $11.40 | $11.40 | $10.32 | 2,214,535 | |
| $11.26 | -0.67 | -5.6% | $12.15 | $12.26 | $11.07 | 2,868,605 | |
| $11.93 | +0.19 | +1.6% | $11.85 | $12.15 | $11.65 | 913,958 | |
| $11.74 | +0.03 | +0.3% | $11.68 | $12.17 | $11.56 | 545,067 | |
| $11.71 | -0.06 | -0.5% | $11.69 | $11.98 | $11.50 | 772,655 | |
| $11.77 | +0.05 | +0.4% | $11.75 | $11.89 | $11.62 | 802,136 | |
| $11.72 | -0.17 | -1.4% | $11.93 | $12.00 | $11.42 | 1,143,788 | |
| $11.89 | -0.71 | -5.6% | $12.60 | $12.61 | $11.70 | 1,175,822 | |
| $12.60 | +0.34 | +2.8% | $12.35 | $12.73 | $12.21 | 1,212,987 | |
| $12.26 | +0.13 | +1.1% | $12.20 | $12.32 | $12.06 | 1,128,251 | |
| $12.13 | -0.47 | -3.7% | $12.57 | $12.64 | $12.02 | 1,598,225 | |
| $12.60 | -0.05 | -0.4% | $12.84 | $13.02 | $12.43 | 1,387,821 | |
| $12.65 | -0.34 | -2.6% | $12.94 | $13.01 | $12.59 | 1,496,070 | |
| $12.99 | -0.91 | -6.5% | $13.84 | $13.88 | $12.87 | 1,265,327 | |
| $13.90 | -0.17 | -1.2% | $14.35 | $14.38 | $13.38 | 1,787,426 | |
| $14.07 | -0.25 | -1.7% | $14.24 | $14.74 | $13.88 | 1,173,907 | |
| $14.32 | +0.06 | +0.4% | $14.21 | $14.34 | $13.83 | 1,064,551 | |
| $14.26 | -0.01 | -0.1% | $14.28 | $14.87 | $14.13 | 1,146,124 | |
| $14.27 | +0.43 | +3.1% | $13.55 | $14.29 | $13.44 | 1,197,280 | |
| $13.84 | -0.54 | -3.8% | $14.12 | $14.31 | $13.79 | 804,585 | |
| $14.38 | +0.16 | +1.1% | $14.50 | $14.59 | $14.06 | 672,732 | |
| $14.22 | -0.09 | -0.6% | $14.38 | $15.00 | $13.81 | 1,530,364 | |
| $14.31 | +0.37 | +2.7% | $13.81 | $14.32 | $13.71 | 796,289 | |
| $13.94 | +0.56 | +4.2% | $13.39 | $14.11 | $13.12 | 1,109,726 | |
| $13.38 | -0.94 | -6.6% | $14.29 | $14.30 | $13.37 | 884,651 | |
| $14.32 | -0.06 | -0.4% | $14.28 | $14.57 | $14.19 | 1,081,002 | |
| $14.38 | -0.18 | -1.2% | $14.44 | $14.62 | $14.10 | 997,716 | |
| $14.56 | +0.785 | +5.7% | $14.06 | $14.84 | $14.00 | 1,098,767 | |
| $13.78 | -0.525 | -3.7% | $14.03 | $14.29 | $13.29 | 1,999,000 | |
| $14.30 | -0.48 | -3.2% | $14.80 | $15.00 | $14.17 | 969,159 | |
| $14.78 | -0.99 | -6.3% | $15.62 | $15.90 | $14.72 | 1,021,633 | |
| $15.77 | +0.74 | +4.9% | $15.58 | $16.21 | $15.35 | 1,070,233 | |
| $15.03 | -0.35 | -2.3% | $15.03 | $15.38 | $14.70 | 1,131,845 | |
| $15.38 | -0.12 | -0.8% | $15.53 | $15.69 | $15.36 | 815,979 | |
| $15.50 | -0.34 | -2.1% | $15.72 | $15.83 | $15.37 | 509,501 | |
| $15.84 | -0.11 | -0.7% | $16.08 | $16.25 | $15.79 | 682,350 | |
| $15.95 | +0.19 | +1.2% | $15.87 | $16.27 | $15.77 | 780,929 | |
| $15.76 | -0.06 | -0.4% | $15.97 | $16.08 | $15.54 | 704,412 | |
| $15.82 | -0.06 | -0.4% | $15.77 | $16.10 | $15.53 | 834,454 | |
| $15.88 | +0.17 | +1.1% | $15.82 | $16.12 | $15.65 | 1,031,391 | |
| $15.71 | +0.10 | +0.6% | $15.62 | $16.36 | $15.56 | 1,082,142 | |
| $15.61 | -0.47 | -2.9% | $16.25 | $16.86 | $15.09 | 1,980,637 | |
| $16.08 | +0.70 | +4.6% | $15.79 | $16.32 | $15.45 | 2,821,583 | |
| $15.38 | -1.14 | -6.9% | $16.64 | $17.17 | $15.21 | 2,317,063 |
- Ticker
- NASDAQ:GLUE
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 28, 2026
Monte Rosa Therapeutics Announces Milestone Achievement Associated with Second Phase 2 Clinical Study Initiation for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)
Latest deck · October 2026
Investor Presentation (October 2026)
Investor deck · 86 slides
Calls
Replays
Monte Rosa Therapeutics (NASDAQ:GLUE) Q4 2024 Earnings Call
Thu, Mar 20, 2025 · 8:00 AM ET
Watch Transcript
Latest news
Monte Rosa Therapeutics Announces Milestone Achievement Associated with Second Phase 2 Clinical Study Initiation for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)
Oct 28, 2026
Closed $10.85 (+1.8%) on Oct 28, 2026
Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 2, 2026
Closed $10.27 (-2.2%) on Oct 5, 2026
Monte Rosa Therapeutics Announces Positive Results for MRT-8102 in GFORCE-1 Phase 1 Study Showing Normalization of Key Pathogenic Drivers of ASCVD in Subjects with Elevated CVD Risk
Oct 1, 2026
Closed $11.26 (-5.6%) on Oct 1, 2026
Monte Rosa Therapeutics to Present Results of MRT-8102 GFORCE-1 Phase 1 Study in Subjects with Elevated Cardiovascular Disease Risk
Sep 30, 2026
Closed $11.26 (-5.6%) on Oct 1, 2026
Monte Rosa Therapeutics Announces Milestone Achievement Associated with Initiation of Phase 2 Clinical Study for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)
Sep 8, 2026
Closed $14.27 (+3.1%) on Sep 8, 2026
Monte Rosa Therapeutics Announces First Patient Dosed in MODeFIRe-1, a Phase 2 Study of MRT-2359 in Combination with Apalutamide in Patients with AR Mutation-Positive Metastatic Castration-Resistant Prostate Cancer
Aug 24, 2026
Closed $13.78 (-3.7%) on Aug 24, 2026
Monte Rosa Therapeutics: Q2 Earnings Snapshot
Aug 6, 2026
Closed $15.71 (+0.6%) on Aug 6, 2026
Monte Rosa Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates
Aug 6, 2026
Closed $15.71 (+0.6%) on Aug 6, 2026
Monte Rosa Therapeutics Announces First Quarter 2026 Financial Results and Business Updates
May 7, 2026
Closed $19.81 (-2.8%) on May 7, 2026
Decks
Investor Presentation (October 2026)
Investor deck · 86 slides · October 2026
Technical Presentation (October 2026)
Technical · 44 slides · Oct 1, 2026
Keystone 2026
Conference · 15 slides · Jan 21, 2026
Technical Presentation (January 2026)
Technical · 26 slides · Jan 7, 2026
Monte Rosa Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 23 in the last 12 months · 82 in all · newest Oct 28, 2026 · oldest 2021
- Calls
- 1 call with a replay · 1 with a transcript · latest Mar 20, 2025
- Decks
- 23 decks · latest October 2026
Where Monte Rosa Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:GLUE · Home listing · This page | NASDAQ | United States | USD |
| BOATS:GLUE | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Monte Rosa Therapeutics, Inc.